Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4502-4511
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4502
Table 1 Baseline data analysis, n (%)
ParameterICG group(n = 12)Non-ICG group(n = 30)P-value
Age (yr, mean ± SD)60.3 ± 9.658.5 ± 9.50.587
Gender0.200
Male5 (41.7)19 (63.3)
Female7 (58.3)11 (36.7)
BMI (kg/m2, mean ± SD)24.8 ± 2.825.3 ± 3.10.602
ASA category0.785
I2 (16.7)3 (10)
II8 (66.7)23 (76.7)
III2 (16.7)4 (13.3)
Concomitant disease1.000
Yes4 (33.3)9 (30)
No8 (66.7)21 (70)
Type of operation
Low anterior resection8 (66.7)16 (53.3)0.430
Abdominoperineal resection4 (33.3)14 (46.7)
Preoperative chemoradiotherapy2 (16.7)10 (33.3)0.483
Tumor differentiation0.879
Moderate7 (58.3)20 (66.7)
Poor5 (41.7)10 (33.3)
Tumor size (cm, mean ± SD)3.5 ± 1.43.4 ± 1.90.996
Table 2 Compared analysis of clinical and pathological outcomes in different groups, n (%)
OutcomeICG group(n = 12)Non-ICG group (n = 30)P-value
LPND0.953
Unilateral dissection10 (83.3)23 (76.7)
Bilateral dissection2 (16.7)7 (23.3)
LPNM0.443
Yes3 (25)3 (10)
No9 (75)27 (90)
Operative time (min, mean ± SD)255.7 ± 65.2273.1 ± 73.30.108
Blood loss (mL, mean ± SD)55.8 ± 37.5108.0 ± 52.70.003
Conversion to laparotomy (case)0 (0)2 (6.67)1.000
Number of LPLNs harvested11.5 ± 5.97.1 ± 4.80.017
pT stage0.694
I3 (25)3 (10)
II2 (16.7)6 (20)
III6 (50)18 (60)
IV1 (8.3)3 (10)
pN stage0.516
06 (50.0)13 (43.3)
12 (16.7)10 (33.3)
24 (33.3)7 (23.4)
pTNM stage0.805
I4 (33.3)7 (23.3)
II2 (16.7)6 (20)
III6 (50)17 (56.7)
Postoperative complication (case)1 (8.33)4 (23.33)1.000
Hospital stay (d, mean ± SD)9.2 ± 1.69.7 ± 2.00.393